Is OGI or OKUR more undervalued in 2026?

CirclFi compares Organigram Global Inc. (OGI) and OnKure Therapeutics, Inc. (OKUR) using 13 institutional-grade valuation models. OGI has a Quality of Company score of 5.6/10 while OKUR scores 5.6/10.

Which is a better buy — OGI or OKUR?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do OGI and OKUR valuations compare?

OGI at $1.14 and OKUR at $4.20 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

OGI vs OKUR Valuation Comparison 2026 — Intrinsic Value Analysis

OGI

Pharmaceutical Preparations

Organigram Global Inc.

Quality

5.6

out of 10

Value Trap

—

Price

$1.14

Last close

Models

11/13

Active

OKUR

Pharmaceutical Preparations

OnKure Therapeutics, Inc.

Quality

5.6

out of 10

Value Trap

LOW

Price

$4.20

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	OGI Fair Value	OGI Upside	OKUR Fair Value	OKUR Upside
Bayesian DCF	Intrinsic	$0.69	-39.3%	$3.02	-28.2%
Earnings Power Value	Intrinsic	$2.38	+67.7%	$7.86	+66.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for OGI vs OKUR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

OGI vs OKUR — Which Stock Is More Undervalued?

OGI scores higher with a 5.6/10 quality rating vs OKUR's 5.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Organigram Global Inc. (OGI) and OnKure Therapeutics, Inc. (OKUR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

OGI currently trades at $1.14 with a QOC of 5.6/10, while OKUR trades at $4.20 with a QOC of 5.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).